Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs SANJIVANI PA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS SANJIVANI PA DECIPHER LABS/
SANJIVANI PA
 
P/E (TTM) x -2.1 29.7 - View Chart
P/BV x 0.6 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DECIPHER LABS   SANJIVANI PA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
SANJIVANI PA
Mar-23
DECIPHER LABS/
SANJIVANI PA
5-Yr Chart
Click to enlarge
High Rs6368 92.6%   
Low Rs1425 56.7%   
Sales per share (Unadj.) Rs45.135.5 127.1%  
Earnings per share (Unadj.) Rs-2.74.5 -58.9%  
Cash flow per share (Unadj.) Rs-2.25.4 -41.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.0-3.1 -748.3%  
Shares outstanding (eoy) m10.1010.00 101.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.3 65.3%   
Avg P/E ratio x-14.510.3 -141.1%  
P/CF ratio (eoy) x-17.38.6 -200.8%  
Price / Book Value ratio x1.7-15.1 -11.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m389464 83.9%   
No. of employees `000NANA-   
Total wages/salary Rs m41229 1,415.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m456355 128.4%  
Other income Rs m749 783.3%   
Total revenues Rs m529364 145.3%   
Gross profit Rs m-10653 -202.3%  
Depreciation Rs m49 48.2%   
Interest Rs m54 134.3%   
Profit before tax Rs m-4249 -84.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-154 -341.1%   
Profit after tax Rs m-2745 -59.4%  
Gross profit margin %-23.314.8 -157.5%  
Effective tax rate %35.58.8 405.7%   
Net profit margin %-5.912.7 -46.3%  
BALANCE SHEET DATA
Current assets Rs m20183 243.0%   
Current liabilities Rs m50227 21.9%   
Net working cap to sales %33.2-40.5 -81.9%  
Current ratio x4.10.4 1,110.5%  
Inventory Days Days3053 56.6%  
Debtors Days Days78920,452,423 0.0%  
Net fixed assets Rs m71127 55.5%   
Share capital Rs m101100 101.0%   
"Free" reserves Rs m131-131 -100.3%   
Net worth Rs m232-31 -755.7%   
Long term debt Rs m08 0.0%   
Total assets Rs m272210 129.3%  
Interest coverage x-7.614.8 -51.7%   
Debt to equity ratio x0-0.2 -0.0%  
Sales to assets ratio x1.71.7 99.3%   
Return on assets %-8.123.2 -35.0%  
Return on equity %-11.6-146.9 7.9%  
Return on capital %-15.8-229.4 6.9%  
Exports to sales %063.8 0.0%   
Imports to sales %03.5 0.0%   
Exports (fob) Rs mNA227 0.0%   
Imports (cif) Rs mNA13 0.0%   
Fx inflow Rs m0227 0.0%   
Fx outflow Rs m013 0.0%   
Net fx Rs m0214 0.0%   
CASH FLOW
From Operations Rs m-1647 -33.4%  
From Investments Rs m-43-10 431.5%  
From Financial Activity Rs m-22-37 57.6%  
Net Cashflow Rs m-800 21,597.3%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 16.4 0.0 -  
Indian inst/Mut Fund % 0.0 6.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 67.7 123.5%  
Shareholders   34,511 4,500 766.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on COMBAT DRUGS vs SANJIVANI PA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs SANJIVANI PA Share Price Performance

Period COMBAT DRUGS SANJIVANI PA S&P BSE HEALTHCARE
1-Day 0.68% -1.54% 1.18%
1-Month -17.62% -14.43% -0.75%
1-Year -1.07% 382.32% 61.82%
3-Year CAGR -24.12% 138.94% 18.16%
5-Year CAGR -10.83% 100.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the SANJIVANI PA share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of SANJIVANI PA the stake stands at 32.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of SANJIVANI PA.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SANJIVANI PA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of SANJIVANI PA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.